安特里斯科技 AVR
$5.69 +$0.11 (+1.97%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $5.75 +1.05%
开盘$5.55
昨收$5.58
当日区间$5.47 – $5.79
成交量1.22M
市值$554.54M
市盈率（TTM）–
股息率–
AVR 相关新闻
匹配 Anteris Technologies Global 或代码 AVR 的头条新闻，按最新排序。
- Cantor Fitzgerald Remains a Buy on Anteris Technologies Global Corp. (AVR)
- Wells Fargo Maintains Anteris Technologies Global(AVR.US) With Buy Rating, Maintains Target Price $16
- Analysts Offer Insights on NA Companies: BETA Technologies, Inc. Class A (BETA) and Anteris Technologies Global Corp. (AVR)
- Anteris Technologies Global(AVR.US) 10% Shareholder Sells US$5.79 Million in Common Stock
- TD Cowen Maintains Anteris Technologies Global(AVR.US) With Buy Rating, Maintains Target Price $15
- Analysts Offer Insights on Healthcare Companies: Anteris Technologies Global Corp. (AVR) and Kymera Therapeutics (KYMR)
- Analysts Conflicted on These Healthcare Names: Anteris Technologies Global Corp. (AVR), Lifecore Biomedical (LFCR) and Biogen (BIIB)
- Analysts Offer Insights on Healthcare Companies: Nuvalent (NUVL), Cogent Biosciences (COGT) and Anteris Technologies Global Corp. (AVR)
- Analysts Offer Insights on Healthcare Companies: Anteris Technologies Global Corp. (AVR) and Siemens Healthineers AG (OtherSEMHF)
- Barclays Maintains Anteris Technologies Global(AVR.US) With Buy Rating, Raises Target Price to $18 正面
- Barclays Reaffirms Their Buy Rating on Anteris Technologies Global Corp. (AVR)
- Cantor Fitzgerald Sticks to Their Buy Rating for Anteris Technologies Global Corp. (AVR)
- Anteris Technologies Raised to Buy From Spec Buy by Bell Potter AVR.AU 正面
- Barclays Maintains Anteris Technologies Global(AVR.US) With Buy Rating, Cuts Target Price to $17 负面
- Wells Fargo Initiates Anteris Technologies Global(AVR.US) With Buy Rating, Announces Target Price $16
暂无评论——快来第一个聊聊 AVR。